COVID-19 Comes 40 Years After AIDS - Any Lesson?
Identifieur interne : 001819 ( Main/Exploration ); précédent : 001818; suivant : 001820COVID-19 Comes 40 Years After AIDS - Any Lesson?
Auteurs : Vicente Soriano [Espagne] ; Pablo Barreiro [Espagne] ; José Manuel Ramos ; José M. Eir S ; Carmen De Mendoza [Espagne]Source :
- AIDS reviews [ 1698-6997 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (génétique), Betacoronavirus (pathogénicité), Contrôle des maladies transmissibles (MeSH), Espagne (épidémiologie), Humains (MeSH), Indice de gravité de la maladie (MeSH), Infections à VIH (épidémiologie), Infections à coronavirus (immunologie), Infections à coronavirus (thérapie), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Pandémies (MeSH), Pneumopathie virale (immunologie), Pneumopathie virale (thérapie), Pneumopathie virale (transmission), Pneumopathie virale (épidémiologie), Syndrome d'immunodéficience acquise (épidémiologie).
- MESH :
- génétique : Betacoronavirus.
- immunologie : Infections à coronavirus, Pneumopathie virale.
- pathogénicité : Betacoronavirus.
- thérapie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Espagne, Infections à VIH, Infections à coronavirus, Pneumopathie virale, Syndrome d'immunodéficience acquise.
- Contrôle des maladies transmissibles, Humains, Indice de gravité de la maladie, Pandémies.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Acquired Immunodeficiency Syndrome (epidemiology), Betacoronavirus (genetics), Betacoronavirus (pathogenicity), COVID-19 (MeSH), Communicable Disease Control (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (immunology), Coronavirus Infections (therapy), Coronavirus Infections (transmission), Cytokine Release Syndrome (immunology), HIV Infections (epidemiology), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Pneumonia, Viral (immunology), Pneumonia, Viral (therapy), Pneumonia, Viral (transmission), SARS-CoV-2 (MeSH), Severity of Illness Index (MeSH), Spain (epidemiology).
- MESH :
- geographic , epidemiology : Spain.
- epidemiology : Acquired Immunodeficiency Syndrome, Coronavirus Infections, HIV Infections, Pneumonia, Viral.
- genetics : Betacoronavirus.
- immunology : Coronavirus Infections, Cytokine Release Syndrome, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Communicable Disease Control, Humans, Pandemics, SARS-CoV-2, Severity of Illness Index.
Abstract
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being "with" rather than "by" SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of orticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic.
DOI: 10.24875/AIDSRev.M20000030
PubMed: 32412509
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 Comes 40 Years After AIDS - Any Lesson?</title><author><name sortKey="Soriano, Vicente" sort="Soriano, Vicente" uniqKey="Soriano V" first="Vicente" last="Soriano">Vicente Soriano</name><affiliation wicri:level="3"><nlm:affiliation>UNIR Medical Center and Health Sciences School, UNIR, Madrid.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>UNIR Medical Center and Health Sciences School, UNIR</wicri:orgArea></affiliation></author><author><name sortKey="Barreiro, Pablo" sort="Barreiro, Pablo" uniqKey="Barreiro P" first="Pablo" last="Barreiro">Pablo Barreiro</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases Unit, Carlos III-La Paz University Hospital, Madrid. Spain.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>Infectious Diseases Unit, Carlos III-La Paz University Hospital</wicri:orgArea></affiliation></author><author><name sortKey="Ramos, Jose Manuel" sort="Ramos, Jose Manuel" uniqKey="Ramos J" first="José Manuel" last="Ramos">José Manuel Ramos</name><affiliation><nlm:affiliation>University General Hospital, Alicante and Medical School, Miguel Hernández University, Elche. Spain.</nlm:affiliation><wicri:noCountry code="subField">Elche</wicri:noCountry></affiliation></author><author><name sortKey="Eir S, Jose M" sort="Eir S, Jose M" uniqKey="Eir S J" first="José M" last="Eir S">José M. Eir S</name><affiliation><nlm:affiliation>Rio Hortega University Hospital, Valladolid. Spain.</nlm:affiliation><wicri:noCountry code="subField">Valladolid</wicri:noCountry></affiliation></author><author><name sortKey="De Mendoza, Carmen" sort="De Mendoza, Carmen" uniqKey="De Mendoza C" first="Carmen" last="De Mendoza">Carmen De Mendoza</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Internal Medicine, Puerta de Hierro University Hospital, Madrid. Spain.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>Laboratory of Internal Medicine, Puerta de Hierro University Hospital</wicri:orgArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32412509</idno><idno type="pmid">32412509</idno><idno type="doi">10.24875/AIDSRev.M20000030</idno><idno type="wicri:Area/Main/Corpus">001684</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001684</idno><idno type="wicri:Area/Main/Curation">001684</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001684</idno><idno type="wicri:Area/Main/Exploration">001684</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 Comes 40 Years After AIDS - Any Lesson?</title><author><name sortKey="Soriano, Vicente" sort="Soriano, Vicente" uniqKey="Soriano V" first="Vicente" last="Soriano">Vicente Soriano</name><affiliation wicri:level="3"><nlm:affiliation>UNIR Medical Center and Health Sciences School, UNIR, Madrid.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>UNIR Medical Center and Health Sciences School, UNIR</wicri:orgArea></affiliation></author><author><name sortKey="Barreiro, Pablo" sort="Barreiro, Pablo" uniqKey="Barreiro P" first="Pablo" last="Barreiro">Pablo Barreiro</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases Unit, Carlos III-La Paz University Hospital, Madrid. Spain.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>Infectious Diseases Unit, Carlos III-La Paz University Hospital</wicri:orgArea></affiliation></author><author><name sortKey="Ramos, Jose Manuel" sort="Ramos, Jose Manuel" uniqKey="Ramos J" first="José Manuel" last="Ramos">José Manuel Ramos</name><affiliation><nlm:affiliation>University General Hospital, Alicante and Medical School, Miguel Hernández University, Elche. Spain.</nlm:affiliation><wicri:noCountry code="subField">Elche</wicri:noCountry></affiliation></author><author><name sortKey="Eir S, Jose M" sort="Eir S, Jose M" uniqKey="Eir S J" first="José M" last="Eir S">José M. Eir S</name><affiliation><nlm:affiliation>Rio Hortega University Hospital, Valladolid. Spain.</nlm:affiliation><wicri:noCountry code="subField">Valladolid</wicri:noCountry></affiliation></author><author><name sortKey="De Mendoza, Carmen" sort="De Mendoza, Carmen" uniqKey="De Mendoza C" first="Carmen" last="De Mendoza">Carmen De Mendoza</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Internal Medicine, Puerta de Hierro University Hospital, Madrid. Spain.</nlm:affiliation><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName><wicri:orgArea>Laboratory of Internal Medicine, Puerta de Hierro University Hospital</wicri:orgArea></affiliation></author></analytic><series><title level="j">AIDS reviews</title><idno type="eISSN">1698-6997</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (epidemiology)</term><term>Betacoronavirus (genetics)</term><term>Betacoronavirus (pathogenicity)</term><term>COVID-19 (MeSH)</term><term>Communicable Disease Control (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (immunology)</term><term>Coronavirus Infections (therapy)</term><term>Coronavirus Infections (transmission)</term><term>Cytokine Release Syndrome (immunology)</term><term>HIV Infections (epidemiology)</term><term>Humans (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (immunology)</term><term>Pneumonia, Viral (therapy)</term><term>Pneumonia, Viral (transmission)</term><term>SARS-CoV-2 (MeSH)</term><term>Severity of Illness Index (MeSH)</term><term>Spain (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (génétique)</term><term>Betacoronavirus (pathogénicité)</term><term>Contrôle des maladies transmissibles (MeSH)</term><term>Espagne (épidémiologie)</term><term>Humains (MeSH)</term><term>Indice de gravité de la maladie (MeSH)</term><term>Infections à VIH (épidémiologie)</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (thérapie)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (épidémiologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (immunologie)</term><term>Pneumopathie virale (thérapie)</term><term>Pneumopathie virale (transmission)</term><term>Pneumopathie virale (épidémiologie)</term><term>Syndrome d'immunodéficience acquise (épidémiologie)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>Coronavirus Infections</term><term>HIV Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term><term>Cytokine Release Syndrome</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Infections à VIH</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Syndrome d'immunodéficience acquise</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Communicable Disease Control</term><term>Humans</term><term>Pandemics</term><term>SARS-CoV-2</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Contrôle des maladies transmissibles</term><term>Humains</term><term>Indice de gravité de la maladie</term><term>Pandémies</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being "with" rather than "by" SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of orticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32412509</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1698-6997</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>07</Month><Day>08</Day></PubDate></JournalIssue><Title>AIDS reviews</Title><ISOAbbreviation>AIDS Rev</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Comes 40 Years After AIDS - Any Lesson?</ArticleTitle><Pagination><MedlinePgn>63-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/AIDSRev.M20000030</ELocationID><Abstract><AbstractText>The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being "with" rather than "by" SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of orticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soriano</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>UNIR Medical Center and Health Sciences School, UNIR, Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreiro</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Carlos III-La Paz University Hospital, Madrid. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>José Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University General Hospital, Alicante and Medical School, Miguel Hernández University, Elche. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eirós</LastName><ForeName>José M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Rio Hortega University Hospital, Valladolid. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Mendoza</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Internal Medicine, Puerta de Hierro University Hospital, Madrid. Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>AIDS Rev</MedlineTA><NlmUniqueID>101134876</NlmUniqueID><ISSNLinking>1139-6121</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32412509</ArticleId><ArticleId IdType="pii">s113961211409</ArticleId><ArticleId IdType="doi">10.24875/AIDSRev.M20000030</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><noCountry><name sortKey="Eir S, Jose M" sort="Eir S, Jose M" uniqKey="Eir S J" first="José M" last="Eir S">José M. Eir S</name><name sortKey="Ramos, Jose Manuel" sort="Ramos, Jose Manuel" uniqKey="Ramos J" first="José Manuel" last="Ramos">José Manuel Ramos</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Soriano, Vicente" sort="Soriano, Vicente" uniqKey="Soriano V" first="Vicente" last="Soriano">Vicente Soriano</name></region><name sortKey="Barreiro, Pablo" sort="Barreiro, Pablo" uniqKey="Barreiro P" first="Pablo" last="Barreiro">Pablo Barreiro</name><name sortKey="De Mendoza, Carmen" sort="De Mendoza, Carmen" uniqKey="De Mendoza C" first="Carmen" last="De Mendoza">Carmen De Mendoza</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001819 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001819 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32412509
|texte= COVID-19 Comes 40 Years After AIDS - Any Lesson?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32412509" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |